AB-Biotics, S.A. Company Profile
The company is a global leader in biotechnology and has divided its activities into probiotics & precision medicines.
AB-Biotics
Biotechnology
- Type
Public
- Headquarters
Spain
- Establishment
2004
- Key Management
Mr. Miquel Angel Bonachera(CEO)
- Revenue (MnUS$)
~14.02 (2018)
- Headcount
~50
- Website
Business Description
AB-Biotics, a spin-off of UAB’s Autonomous University of Barcelona, was established in 2004. The company is a global leader in biotechnology and has divided its activities into probiotics & precision medicines. Its business model is based on research and development, intellectual property protection, and distribution of biotechnological solutions via a Business Business, (B2B) model. The company sells products to the pharmaceutical, dietary supplement, and functional foods industries.
It operates in 66 different countries and has 135 product references. Probiotic products are offered by the company, including cardiometabolic products like AB-LIFE Forte and AB-LIFE Plus, LipiGO and AB-Fortis, as well as oral care products like AB-Dentalac Pro, AB-Dentalac Junior, and AB-Dentalac Junior. It offers lab services and genetic tests, including those for fertility, pain medicine, behavioral health, and fertility. AB-Biotics, S.A., was founded in 2004. It is based in Barcelona, Spain
Key Financials
Revenue (US$ Mn):
Operating Income (US$ Mn):
Net Income(US$Mn):
Operating Margin %:
Gross Margin %:
SWOT Analysis
Strengths
Get this premium content
